Suchergebnisse - "Shiraishi, Yoshimasa"

PubPharm (71)

1

Osimertinib readministration for central nervous system metastases in non-small cell lung cancer positive for EGFR activating mutations

enthalten in: Respiratory investigation | 2024

von Inutsuka, Y. | Iwama, E. | Shiraishi, Y. | +4

2

Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer : A case report and literature review

enthalten in: Thoracic cancer | 2024

von Yamamoto, Y. | Shibahara, D. | Mori, T. | +7

3

Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer

enthalten in: British journal of cancer | 2024

von Haratani, K. | Nakamura, A. | Mamesaya, N. | +22

4

Osimertinib readministration for central nervous system metastases in non–small cell lung cancer positive for EGFR activating mutations

enthalten in: ResearchSquare.com | 2024

von Inutsuka, Y. | Iwama, E. | Shiraishi, Y. | +4

5

Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer : TORG1937 (DATE Study)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Nakamichi, S. | Kubota, K. | Misumi, T. | +17

6

Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Shiraishi, Y. | Kishimoto, J. | Sugawara, S. | +25

7

Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab : A Case Report

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Shiraishi, Y. | Tokito, T. | Toyozawa, R. | +5

8

Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma

enthalten in: JTO clinical and research reports | 2024

von Hazama, D. | Nakahama, K. | Kodama, H. | +18

9

Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non-Small Cell Lung Cancer : The DOLPHIN Phase 2 Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2023

von Tachihara, M. | Tsujino, K. | Ishihara, T. | +15

10

Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum-based chemotherapy

enthalten in: Thoracic cancer | 2023

von Nakatsuru, K. | Tsubouchi, K. | Hirahata, M. | +6

1
2
3
4
5
6
7
8
Nächster »
[8]